| RE49935 | Crystalline polymorphs of benfotiamine, process for preparation and its use thereof | Feb 07, 22 | Apr 23, 24 | SHANGHAI RAISING PHARMACEUTICAL CO., LTD. |
| RE49687 | Thienopyrimidine and thienopyridine compounds and methods of use thereof | Feb 02, 21 | Oct 10, 23 | The Regents of the University of Michigan; KURA ONCOLOGY, INC.; |
| RE49431 | RNA interference agents for GST-PI gene modulation | Aug 11, 20 | Feb 28, 23 | Nitto Denko Corporation |
| RE49299 | Method of producing porous metal-carbon materials | Feb 14, 18 | Nov 15, 22 | Powermers Inc. |
| RE49229 | Methods and compositions for treating malignant tumors associated with KRAS mutation | Feb 28, 20 | Oct 04, 22 | Nitto Denko Corporation |
| RE49222 | Fluorine-containing complex compound, and production method for fluorine-containing organic compound employing same | Oct 30, 19 | Sep 27, 22 | DAIKIN INDUSTRIES, LTD.; Osaka University; |
| RE48887 | RNA interference compositions and methods for malignant tumors | Sep 19, 19 | Jan 11, 22 | Nitto Denko Corporation |
| RE48809 | Organic electroluminescent materials and devices | Sep 26, 19 | Nov 02, 21 | The Trustees of Princeton University and Universal Display Corporation |
| RE48547 | Aminopyrimidinecarboxamides as CXCR2 modulators | Mar 24, 17 | May 11, 21 | Syntrix Biosystems Inc. |
| RE48510 | Phosphorus functional antimicrobial coatings for metal surfaces | Mar 28, 18 | Apr 13, 21 | Nano Safe Coatings Incorporated |
| RE48266 | Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto | Mar 25, 19 | Oct 20, 20 | Vertex Pharmaceuticals Incorporated |
| RE48165 | Alkenyl (perfluoroalkyl) phosphinic acids | Mar 01, 19 | Aug 18, 20 | Merck Patent GmbH |
| RE47797 | Intermediates for the preparation of analogs of halichondrin B | Apr 03, 18 | Jan 07, 20 | EISAI R&D MANAGEMENT CO., LTD. |
| RE47787 | Process for preparing ceftaroline fosamil | Aug 08, 18 | Dec 31, 19 | Sandoz AG |
| RE47740 | Aminopyridinecarboxamides as CXCR2 modulators | Jul 14, 16 | Nov 26, 19 | Syntrix Biosystems Inc. |
| RE47415 | Pyrimidinecarboxamides as CXCR2 modulators | Mar 16, 17 | Jun 04, 19 | Syntrix Biosystems Inc. |
| RE47396 | Compositions and methods for inhibition of the JAK pathway | Oct 20, 15 | May 21, 19 | Rigel Pharmaceuticals Inc. |
| RE47300 | Mitochondrially delivered anti-cancer compounds | Dec 01, 15 | Mar 19, 19 | CANCURE LIMITED |
| RE47267 | Pyridinecarboxamides as CXCR2 modulators | Jun 08, 16 | Mar 05, 19 | Syntrix Biosystems Inc. |
| RE46965 | Intermediates for the preparation of analogs of Halichondrin B | Jun 24, 13 | Jul 24, 18 | Eisai R & D Management Co., Ltd. |